Sam Maher
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Microbiology top 2%
- Antimicrobial Peptides and Activities
Papers in
-
- Advanced Drug Delivery Systems 19
- Drug Solubulity and Delivery Systems 13
-
- RNA Interference and Gene Delivery 4
- Protein Hydrolysis and Bioactive Peptides 3
- Co-authors
- David J. Brayden (29 shared papers)Siobhán McClean (8 shared papers)Randall J. Mrsny (2 shared papers)Thomas W. Leonard (2 shared papers)Jette Bredahl Jacobsen (1 shared paper)David P. Fairlie (1 shared paper)Timothy A. Hill (1 shared paper)Luca Casettari (1 shared paper)
- Journals
- Advanced Drug Delivery Reviews (5 papers)European Journal of Pharmaceutical Sciences (3 papers)Expert Opinion on Drug Delivery (2 papers)Biochemical Pharmacology (2 papers)Pharmaceutics (2 papers)
- Partner nations
- IrelandAustraliaUnited States
In The Last Decade
Sam Maher
42 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 124
- Pharmaceutical Science 1.1k
- Microbiology 230
- Biomaterials 219
- Molecular Biology 1.0k
- Neurology 107
Countries citing papers authored by Sam Maher
This map shows the geographic impact of Sam Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Maher more than expected).
Fields of papers citing papers by Sam Maher
This network shows the impact of papers produced by Sam Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Maher. The network helps show where Sam Maher may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam Maher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 313 | |
| 2 | 2006 | 231 | |
| 3 | 2020 | 199 | |
| 4 | 2009 | 198 | |
| 5 | 2019 | 184 | |
| 6 | 2019 | 123 | |
| 7 | 2011 | 90 | |
| 8 | 2013 | 78 | |
| 9 | 2021 | 73 | |
| 10 | 2007 | 71 | |
| 11 | 2011 | 70 | |
| 12 | 2021 | 66 | |
| 13 | 2023 | 60 | |
| 14 | 2014 | 57 | |
| 15 | 2012 | 56 | |
| 16 | 2020 | 55 | |
| 17 | 2009 | 49 | |
| 18 | 2019 | 48 | |
| 19 | 2010 | 47 | |
| 20 | 2008 | 46 |
About Sam Maher
Sam Maher is a scholar working on Pharmaceutical Science, Molecular Biology, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Biomaterials, having authored 42 papers that have together received 2.5k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (19 papers), Drug Solubulity and Delivery Systems (13 papers), Inhalation and Respiratory Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers), Pharmaceutical studies and practices (4 papers), Antimicrobial Peptides and Activities (3 papers), Protein Hydrolysis and Bioactive Peptides (3 papers) and Barrier Structure and Function Studies (3 papers). The work is most often cited by research in Pharmaceutical Science (1.1k citations), Microbiology (230 citations), Biomaterials (219 citations), Molecular Biology (1.0k citations) and Neurology (107 citations). Sam Maher has collaborated with scholars based in Ireland, Australia and United States. Frequent co-authors include David J. Brayden, Siobhán McClean, Randall J. Mrsny, Thomas W. Leonard, Jette Bredahl Jacobsen, David P. Fairlie, Timothy A. Hill, Luca Casettari, Sarinj Fattah and Lisbeth Illum. Their work appears in journals such as Advanced Drug Delivery Reviews, European Journal of Pharmaceutical Sciences, Expert Opinion on Drug Delivery, Biochemical Pharmacology and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.